Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
10/2002
10/10/2002US20020146397 Unblocking immunization at a regional lymph node by: promoting differentiation and maturation of immature dendritic cells in a regional lymph node and; allowing presentation by resulting mature dendritic cells of antigen to T-cells
10/10/2002US20020146392 Helper dependent adenovirus vectors based on site-specific recombinases
10/10/2002US20020146391 For diagnosis and therapy of susceptibility to atopic allergy, asthma
10/10/2002US20020146389 For inducing apoptosis in mammalian cancer cells; stimulating a proinflammatory response in mammalian cells
10/10/2002DE10143106C1 Amplifying RNA, useful e.g. for analysis on a microarray, comprises conversion to double-stranded cDNA, strand separation and transcription
10/10/2002DE10117381A1 Herstellung polyklonaler, monospezifischer Antikörper gegen die uPAR-Varianten del4, del5 und del4+5 sowie deren Verwendung für diagnostische und therapeutische Zwecke Production of polyclonal, monospecific antibodies to uPAR variants del4, del5 and del4 + 5 and their use for diagnostic and therapeutic purposes
10/10/2002DE10117359A1 Verfahren zur Oxidation aromatischer Verbindungen Process for the oxidation of aromatic compounds
10/10/2002DE10116594A1 Künstliche Chromosomen, die EHV-Sequenzen umfassen Include artificial chromosomes EHV sequences
10/10/2002DE10116211A1 Kammer zur Behandlung von in einer Suspension enthaltenen Zellen im elektrischen Feld Chamber for treating cells contained in a suspension in the electrical field
10/10/2002DE10116101A1 New nucleic acid construct, useful for transforming microorganism for fermentation, contains sequences for increased production and transport of sulfite
10/10/2002DE10115507A1 Verfahren zur Kodierung von Information in Nukleinsäuren eines genetisch veränderten Organismus The process of encoding information in nucleic acids of a genetically modified organism
10/10/2002DE10114999A1 D-Carbamoylase aus Arthrobacter crystallopoietes DSM 20117 D-carbamoylase from Arthrobacter crystallopoietes DSM 20117
10/10/2002DE10114063A1 New DNA sequences from potato, useful for producing plants with altered properties, e.g. tolerance of flooding, also related proteins, antibodies and inhibitory sequences
10/10/2002DE10108412A1 Ocular pigment epithelial cells, useful for treating e.g. macular degeneration by implantation, are transformed with large-capacity adenoviral vector
10/10/2002CA2455915A1 Methods and compositions for using mhc class ii invariant chain polypeptide as a receptor for macrophage migration inhibitory factor
10/10/2002CA2447183A1 Molecules for disease detection and treatment
10/10/2002CA2446804A1 Secreted streptococcus pneumoniae proteins
10/10/2002CA2443338A1 Lps-responsive chs1/beige-like anchor gene and therapeutic applications thereof
10/10/2002CA2443211A1 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
10/10/2002CA2443189A1 Isolated human phosphatase proteins, nucleic acid molecules encoding human phosphatase proteins, and uses thereof
10/10/2002CA2443176A1 Pseudomonas avr and hop proteins, their encoding nucleic acids, and use thereof
10/10/2002CA2443138A1 Anti-muc-1 single chain antibodies for tumor targeting
10/10/2002CA2443045A1 Mucin peptide with immunoenhancing properties
10/10/2002CA2442829A1 Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof
10/10/2002CA2442808A1 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
10/10/2002CA2442801A1 Recombinant antibodies coexpressed with gntiii
10/10/2002CA2442786A1 Isolated human lipase proteins, nucleic acid molecules encoding human lipase proteins, and uses thereof
10/10/2002CA2442775A1 New polynucleotides and polypeptides of the ifn alpha-21 gene
10/10/2002CA2442774A1 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
10/10/2002CA2442772A1 Isolated human nadph oxidase, nucleic acid molecules encoding said proteins, and uses thereof
10/10/2002CA2442755A1 Methods for modification of plant inflorescence architecture
10/10/2002CA2442684A1 Control of growth and repair of gastro-intestinal tissues by gastrokines and inhibitors
10/10/2002CA2442674A1 Phosphoprotein target for insulin and its antagonists
10/10/2002CA2442627A1 Isolated human enzyme proteins, nucleic acid molecules encoding human enzyme proteins, and uses thereof
10/10/2002CA2442619A1 Cancer-testis antigens
10/10/2002CA2442594A1 Vip3 pesticidal toxin from bacillus thuringiensis
10/10/2002CA2442587A1 Method for improving plant tolerance to environmental stress
10/10/2002CA2442533A1 A simplified and improved method for preparing an antibody or an antibody fragment targeted immunoliposome or polyplex for systemic administration of a therapeutic or diagnostic agent
10/10/2002CA2442531A1 Peptides and antibodies to muc 1 proteins
10/10/2002CA2442496A1 Method for modifying plant biomass
10/10/2002CA2442495A1 Alpha conotoxin peptides with analgesic properties
10/10/2002CA2442363A1 Reducing the immunogenicity of fusion proteins
10/10/2002CA2442169A1 Nucleic acid analysis using non-templated nucleotide addition
10/10/2002CA2442149A1 Viral vectors
10/10/2002CA2442123A1 Adp-ribosylating bacterial toxins
10/10/2002CA2442064A1 G-protein coupled receptors
10/10/2002CA2442062A1 Secreted proteins
10/10/2002CA2442024A1 Methods, platforms and kits useful for identifying, isolating and utilizing nucleotide sequences which regulate gene expression in an organism
10/10/2002CA2442022A1 Method of encoding information in nucleic acids of a genetically engineered organism
10/10/2002CA2442020A1 Methods of delivery of exogenous proteins to the cytosol and uses thereof
10/10/2002CA2441984A1 Methods of 6-o-sulfating polysaccharides and 6-o-sulfated polysaccharide preparations
10/10/2002CA2441654A1 Cytoskeleton-associated proteins
10/10/2002CA2441382A1 A hepatitis b virus surface antigen mutant and methods of detection thereof
10/10/2002CA2441212A1 Methods for isolating genes from microorganisms
10/10/2002CA2441084A1 Improved conditionally replicating vectors for inhibiting viral infections
10/10/2002CA2440874A1 Non-typeable haemophilus influenzae immunogenic polypeptides and use thereof
10/10/2002CA2440831A1 Combination therapy using cd40 and cd20 ligands
10/10/2002CA2440265A1 Plastid transformation of lycopersicon plants
10/10/2002CA2440108A1 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
10/10/2002CA2438391A1 Method for correlating gene expression profiles with protein expression profiles
10/10/2002CA2438030A1 Methods of diagnosis of angiogenesis, compositions and methods of screening for angiogenesis modulators
10/10/2002CA2436366A1 Carotenoid biosynthesis
10/10/2002CA2435828A1 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
10/10/2002CA2434677A1 Molecules for diagnostics and therapeutics
10/10/2002CA2431938A1 A novel vaccine formulation consisting of dna vaccine inactivated virus
10/10/2002CA2430684A1 Micromonospora echinospora genes encoding for biosynthesis of calicheamicin and self-resistance thereto
10/10/2002CA2429265A1 Mammalian alpha-helical protein-53
10/10/2002CA2358263A1 Methods
10/09/2002EP1247868A2 Process for the production by fermentation of D-pantothenic acid and/or its salts
10/09/2002EP1247867A1 Gene encoding plant resistance protein to the tomato mosaic tobamovirus (ToMV)
10/09/2002EP1247866A1 DNA polymerases having improved labeled nucleotide incorporation properties
10/09/2002EP1247865A2 Antibody for use in therapy
10/09/2002EP1247864A2 58297, an amino acid transporter and uses therefor
10/09/2002EP1247863A1 Polypeptide and nucleic acid encoding the same
10/09/2002EP1247862A2 Keratinocyte growth factor-2 (KGF-2 or fibroblast growth factor-12, FGF-12)
10/09/2002EP1247861A1 Method of examining vulgar psoriasis
10/09/2002EP1247860A1 Crystal structure of pyruvate dehydrogenase kinase 2 (PDHK-2) and use thereof in methods for identifying and designing new ligands
10/09/2002EP1247817A2 Human CD23-like protein and nucleic acids encoding it
10/09/2002EP1247816A1 Immunogen, antivenom and vaccine against the venom of the black widow spider
10/09/2002EP1247530A2 Keratinocyte growth factor-2 (KGF-2 or fibroblast growth factor-12, FGF-12)
10/09/2002EP1247103A2 Tethered ligands and methods of use
10/09/2002EP1247099A2 Methods and compositions for detecting hepatitis e virus
10/09/2002EP1247095A2 High affinity tcr proteins and methods
10/09/2002EP1246946A2 Compositions and methods for the discovery and selection of biological information
10/09/2002EP1246945A2 Method for identifying a mark applied on a solid body
10/09/2002EP1246944A1 PCR-BASED DETECTION OF i RHIZOCTONIA CEREALIS /i
10/09/2002EP1246942A1 Ferrofluid based arrays
10/09/2002EP1246941A1 Method for concurrent amplification and real time detection of polymorphic nucleic acid sequences
10/09/2002EP1246940A2 Chemotherapeutant screening method
10/09/2002EP1246935A2 Highly conserved genes and their use to generate probes and primers for detection of microorganisms
10/09/2002EP1246933A1 Method for making insulin precursors and insulin precursor analogues having improved fermentation yield in yeast
10/09/2002EP1246931A1 Compositions comprising nucleic acids incorporated in bilaminar mineral particles
10/09/2002EP1246930A1 Replication incompetent herpes virus vectors
10/09/2002EP1246929A2 Methods and compositions for obtaining disease protection for animals
10/09/2002EP1246928A2 Method for increasing the content of fatty acids in plants and micro-organisms
10/09/2002EP1246927A2 Biological control by conditional dominant lethal genetic system
10/09/2002EP1246925A1 Di- or oligomer of a dimer, trimer, quatromer or pentamer of recombinant fusion proteins
10/09/2002EP1246924A2 Dna polymerase mutant having one or more mutations in the active site
10/09/2002EP1246923A2 Dna modification proteins
10/09/2002EP1246922A2 Orynebacterium glutamicum genes encoding phosphoenolpyruvate: sugar phosphotransferase system proteins
1 ... 2692 2693 2694 2695 2696 2697 2698 2699 2700 2701 2702 2703 2704 2705 2706 2707 2708 2709 2710 2711 2712 ... 4023